A Phase 2/3 interventional study of Hyoscine and Promethazine in Labor Pain, sponsored by Mashhad University of Medical Sciences. Completed. Open to female participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2012-07-20.
Sponsored by Mashhad University of Medical Sciences · Phase 2/3 and Interventional
It is always considered to shorten the duration of delivery without compromising the mother and fetus by obstetrics. Hyoscine and Promethazine are used widely in hospital and research is very limited, with conflicting results regarding the efficacy of these two drugs. So the investigators decided to compare of effect of hyoscine N-butyl bromide and Promethazine on length of active phase of the first stage of labor.
396 studies on the registry are indexed under Labor Pain; 66 are open to participants now.
This study's enrollment of 93 is close to the median of 100 across 326 interventional studies indexed under Labor Pain.
Browse Labor Pain studies →Mashhad University of Medical Sciences is the lead sponsor of 90 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
25 mg of promethazine
Drug: Promethazine
20 mg of hyoscine
Drug: Hyoscine
The samples were randomly allocated to inject of 20 mg of hyoscineIM in dilatation 3-5cm.
The samples were randomly allocated to inject of 25 mg of promethazine IM in dilatation 3-5cm.
Effect of Hyoscine and Promethazine on labor pain
Time frame: up to 9 months
No study locations are listed for this record.
This study is completed, as verified in Jul 2012. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Mashhad University of Medical Sciences